Anil Kumar Yadav
Overview
Explore the profile of Anil Kumar Yadav including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramesh M, Yadav A, Pathak P, Basha C
Sci Rep
. 2024 Dec;
14(1):31526.
PMID: 39733153
Autonomous microgrids (ATMG), with green power sources, like solar and wind, require an efficient control scheme to secure frequency stability. The weather and locationally dependent behavior of the green power...
2.
Yadav A, Yadav B, Yadav P, Pandey S, Sarvottam K
Int J Appl Basic Med Res
. 2024 Sep;
14(3):151-155.
PMID: 39310070
Background: Hypobaric hypoxia refers to a condition where there is a decreased oxygen partial pressure in the air due to low atmospheric pressure. It is known to affect the metabolism,...
3.
Gupta R, Yadav A, Jha S
Sci Total Environ
. 2024 Jun;
943:173958.
PMID: 38871320
Accurately and precisely estimating global horizontal irradiance (GHI) poses significant challenges due to the unpredictable nature of climate parameters and geographical limitations. To address this challenge, this study proposes a...
4.
Sinha P, Yadav A
Mol Divers
. 2024 Apr;
29(1):241-254.
PMID: 38615110
Cimicifugae is a commonly used treatment for breast cancer, but the specific molecular mechanisms underlying its effectiveness remain unclear. In this research, we employ a combination of network pharmacology, molecular...
5.
Yadav A, Wang S, Shin Y, Jang B
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474118
c-Met is a tyrosine-kinase receptor, and its aberrant activation plays critical roles in tumorigenesis, invasion, and metastatic spread in many human tumors. PHA-665752 (PHA) is an inhibitor of c-Met and...
6.
Repurposing integrase inhibitors against human T-lymphotropic virus type-1: a computational approach
Sinha P, Yadav A
J Biomol Struct Dyn
. 2024 Jan;
:1-12.
PMID: 38234060
Adult T-cell Lymphoma (ATL) is caused by the delta retrovirus family member known as Human T-cell Leukaemia Type I (HTLV-1). Due to the unavailability of any cure, the study gained...
7.
Borah S, Das B, Bhattacharjya B, Yadav A, Das P, Das S, et al.
Environ Sci Pollut Res Int
. 2024 Jan;
31(7):10533-10544.
PMID: 38198088
The present study was conducted with the objective of developing ecologically and economically feasible pen culture protocols for Labeo catla as an alternate income source for wetland fishers in the...
8.
Sinha P, Yadav A
J Biomol Struct Dyn
. 2023 Nov;
42(24):13663-13679.
PMID: 37921740
Nipah virus (NiV) is one of the most common viral diseases affecting the brain and nervous system of the body. To date, there is no significant antiviral drug specifically designed...
9.
Sinha P, Yadav A
J Biomol Struct Dyn
. 2023 Aug;
42(13):7037-7053.
PMID: 37580968
The quest to identify antiviral drug candidates for dengue and rabies viral diseases is a great challenge for the researchers. While different research is being conducted on the repurposed drugs...
10.
Sinha P, Yadav A
J Biomol Struct Dyn
. 2023 Jul;
42(10):5001-5014.
PMID: 37517053
Rotavirus is one of the most common gastrointestinal viral diseases. Till date, there are only two vaccines available in the markets, which are specifically to be administered to young babies....